Sign in

CIK 0001613780 · Non-accelerated filer<br>Smaller reporting company

DBV Technologies S.A.

Sign in to watch
Ticker
DBVTF
Exchange
Nasdaq, OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
France
Entity type
operating
Phone
330155427878
Business address
107 AVENUE DE LA REPUBLIQUE, CHATILLON, France

Securities

  • DBVT American Depositary Shares Nasdaq
  • DBVTF Common stock OTC
  1. 4 Open-market sale Chief Medical Officer sold 464 shares at $2.70 ($1,253)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Open-market sale Chief Medical Officer sold 534 shares at $4.86 ($2,595)
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market sale Member of 10% owner group sold 3,369,093 shares at an average $4.60 ($15,484,143)
  6. 4 Open-market sale Chief Medical Officer sold 8,120 shares at an average $2.86 ($23,207)
  7. 4 Grant or award Chief Financial Officer acquired 32,000 shares (grant or award)
  8. 4 Grant or award Chief Commercial Officer acquired 55,000 shares (grant or award)
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 4 Open-market sale Chief Medical Officer sold 464 shares at $2.22 ($1,030)
  12. 4 Open-market sale Chief Medical Officer sold 397 shares at $1.84 ($730)
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 4 Derivatives Options or other derivatives
  17. 4 Open-market sale Chief Medical Officer sold 600 shares at $0.85 ($510)
  18. 4 Derivatives Options or other derivatives
  19. 4 Open-market sale Chief Medical Officer sold 907 shares at an average $0.55 ($503)
  20. 4 Open-market sale Chief Medical Officer sold 2,350 shares at $0.54 ($1,269)

Page 1 of 4 · 61 filings